1Griffin S,Pichler R,Dittrich M,et al.Cell cycle control in glomerular disease.Springer Semin Immunopathol,2003,24:441-457.
2Shankland S,Wolf G.Cell cycle regulatory proteins in renal disease:role in hypertrophy,proliferation,and apoptosis.Am J Physiol Renal Physiol,2000,278:F515-F529.
3Cell cycle and glomerular disease:a minireview.Nephron Exp Nephrol,2006,102(2):e39 -48.
4Couser W,Johnson R.Mechanisms of progressive renal disease in glomerulonephritis.Am J Kidney Dis,1994,23:193-198.
5Yamamoto T,Wilson C.Complement dependence of antibody-induced mesangial cell injury in the rat.J Immunol,1987,138:3758-3765.
6Shankland S,Hugo C,Coats S,et al.Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis.Kidney Int,1996,50:1230-1239.
7Pippin J,Qu Q,Meijer L,et al.Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine,a novel cyclin-dependent kinase antagonist.J Clin Invest,1997,100:2512-2520.
9Hiromura K,Pippin J,Fero M,et al.Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1.J Clin Invest,1999,103:597-604.
10Feliers D,Frank M,Riley D.Activation of cyclin D1-CDK4 and CDK4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy.Diabetes,2002,51:3290-3299.
9Kok RJ, Grijpstra F, Walthuis RB, et al. Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme [ J ]. J Pharmacol Exp Ther, 1999, 288( 1 ) :281-285
10Kok RJ, Haverdings RF, Grijpstra F, et al. Targeting of captopril to the kidney reduces renal angiotensin-converting enzyme activity without affecting systemic blood pressure[J].J Pharmacol Exp Ther ,2002 , 301 ( 3 ) : 1139-1143
